Peter E. Carson
Inserm
3 papers in the Anchorcite directory, published between 2004 and 2021, cited 16,481 times in total.
Research topics
- Heart Failure Treatment and Management · 3 papers
- Diabetes Treatment and Management · 2 papers
- Cardiac Arrest and Resuscitation · 1 paper
- Cardiac pacing and defibrillation studies · 1 paper
- Chronic Kidney Disease and Diabetes · 1 paper
- Cardiovascular Function and Risk Factors · 1 paper
Frequent co-authors
- Milton Packer · 2 papers
- Stefan D. Anker · 2 papers
- Javed Butler · 2 papers
- Gerasimos S Filippatos · 2 papers
- Stuart Pocock · 2 papers
- James L. Januzzi · 2 papers
- Subodh Verma · 2 papers
- Hiroyuki Tsutsui · 2 papers
Papers
- Cardiac-Resynchronization Therapy with or without an Implantable Defibrillator in Advanced Chronic Heart FailureNew England Journal of Medicine · 2004 · 5,802 citations
BACKGROUND: We tested the hypothesis that prophylactic cardiac-resynchronization therapy in the form of biventricular stimulation with a pacemaker with or without a defibrillator would reduce the risk of death and hospitalization among patients with advanced chronic heart failure and intraventricular…
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart FailureNew England Journal of Medicine · 2020 · 5,468 citations
BACKGROUNDSodium-glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of hospitalization for heart failure in patients regardless of the presence or absence of diabetes.More evidence is needed regarding the effects of these drugs in patients across the broad spectrum of heart…
- Empagliflozin in Heart Failure with a Preserved Ejection FractionNew England Journal of Medicine · 2021 · 5,211 citations
BACKGROUND: Sodium-glucose cotransporter 2 inhibitors reduce the risk of hospitalization for heart failure in patients with heart failure and a reduced ejection fraction, but their effects in patients with heart failure and a preserved ejection fraction are uncertain. METHODS: In…
Metadata from OpenAlex (CC0).